one drug substance, 2 brands with different indications [Regulatives / Guidelines]

posted by Shuanghe  – Spain, 2011-03-18 17:04 (5582 d 23:13 ago) – Posting: # 6776
Views: 3,693

Thanks Jaime!

❝ I would say, you are right - and the business guy wrong.


yeah... :lol2:

But I need hard evidence to convince them. It would be wonderful if there's guideline or some regulation rules to follow. I couldn't find anything useful in EMA website but that may just due to my lack of knowledge in regulatory process. Usually I'd :google: but this time, well, embarrassingly, I don't even have a clue which key words to use. :confused:
Any further help?
Shuanghe

All the best,
Shuanghe

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,571 registered users;
321 visitors (0 registered, 321 guests [including 17 identified bots]).
Forum time: 17:18 CEST (Europe/Vienna)

It requires a very unusual mind
to undertake the analysis of the obvious.    Alfred North Whitehead

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5